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Abstract 
Introduction: In developed countries, HIV care is mostly provided by trained specialist healthcare 
professionals. Due to the increasing demand for HIV care, pressure on healthcare providers to re-
duce cost and the current global economic constraints, many developed countries are searching 
for alternative HIV care models. This review aims to consider whether HIV treatment and care can 
be provided as effectively and safely by doctors and nurses with no HIV-specialist training com-
pared to those with HIV-specialist training. Methods: Three electronic bibliographic databases 
MEDLINE, EMBASE and the Cochrane Library were searched for studies conducted between Janu-
ary 1996 and March 2015. Manual searches of reference lists of all relevant reports retrieved from 
the electronic databases were conducted. All comparative studies examining the quality of HIV 
care provided by different types of healthcare providers in developed countries were included. 
Results: Nine observational studies involving 27,015 patients were included in the review. Eight 
studies were conducted in the USA and one study in Switzerland. Healthcare providers with HIV- 
related expertise and or training and those without HIV-related expertise or training who col-
laborated with providers with HIV-related expertise and or training outperformed other health-
care providers in many virological, immunological and ART-related outcomes. Conclusion: This 
review found moderate quality evidence that HIV care can be provided effectively by non-HIV spe-
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cialists if they have access to HIV specialists or experts for advice and support. 
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1. Introduction 
In the last two decades, the availability and wide use of combination antiretroviral therapy (cART) in developed 
countries has enabled people living with HIV/AIDS (PLWHA) to live increasingly longer and healthier lives. 
PLWHA who start cART early are expected to receive treatment for up to 50 years [1]-[3]. Care of PLWHA in 
developed countries is mainly provided by clinicians and nurses who have expertise in HIV medicine in special-
ist care centres. For instance, in the USA and the United Kingdom, patients who are diagnosed with HIV are re-
ferred to infectious disease or HIV specialists for further care and treatment. Yet, as more PLWHA are diag-
nosed and treated the need for these providers will increase. However, due to the current economic constraints in 
many developed countries, the present treatment model of mainly relying on HIV specialists for care and treat-
ment of PLWHA will make it more difficult to respond to the increasing demand of HIV care. In order to sustain 
the gains achieved in the fight against HIV/AIDS, an alternative model of care is needed to help offset the an-
ticipated burden on the current healthcare systems while maintaining the same high quality of HIV care. 
Currently, some low- and middle-income countries (LMICs) have turned to models of care such as task- 
shifting and decentralisation of HIV care [4] [5]. Decentralisation of HIV care outside of the hospital settings 
provided by non-HIV specialists has also been implemented in other LMICs and found to be as beneficial as 
HIV care provided in hospital settings [6].  
In developed countries very few studies have examined the effectiveness of task shifting of HIV care to meet 
the needs of the increasing number of PLWHA and offset the rising costs of care. This systematic literature re-
view aims to report on the evidence of the quality of HIV care provided by different types of healthcare profes-
sionals in developed countries in the cART era. 
2. Methods 
Protocol for this review was developed a priori following the methodology outlined by the Centre for Reviews 
and Dissemination [7].  
2.1. Study Inclusion and Exclusion Criteria 
Randomized and controlled clinical trials, cohorts, case control, cross-sectional studies and interrupted time se-
ries with comparison groups that investigated the quality of HIV care provided by different types of healthcare 
professionals were included in this review. Editorials, comments, letters, clinical guidelines or reviews were ex-
cluded. For this review, healthcare providers were defined as health professionals providing medical and nursing 
care and not ancillary care to PLWHA. HIV specialists were defined as clinicians who have received specialised 
HIV training from accredited institutions or those who have self-identified as HIV specialists. Studies that in-
volved healthcare providers who provided ancillary or social care were excluded. Because treatment and care of 
PLWHA has evolved rapidly, only studies that were carried out from 1996 onwards when cART became widely 
and readily available in developed countries were considered. 
All PLWHA aged 18 or older receiving antiretroviral therapy (ART) were included. Participants who required 
specialty care services other than for their HIV (e.g. adults with mental illnesses) were excluded. Study settings 
were developed countries classified as members of the Organization for Economic Cooperation and Develop-
ment (OECD) in 2014 as these countries are socioeconomically comparable and have healthcare systems that are 
fairly representative of other developed nations. 
Commonly measured outcomes in HIV clinical care studies were employed to assess the quality of HIV care 
[8] including reduction in HIV viral load; CD4 cell count; use of ART; hospitalization and length of hospital 
stay; use of appropriate prophylaxis; adherence to ART; appropriate screenings and vaccinations; patient satis-
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faction of care; and non-HIV related interactions due to HIV care and treatment. 
2.2. Search Strategy 
MEDLINE, EMBASE and the Cochrane Library [9] were systematically searched for studies published between 
1996 and 2015 limiting to English articles only. 
A robust search strategy was developed using relevant text words and MeSH or Emtree headings for health-
care providers, clinicians, doctors, nurses, HIV/AIDS, ART, OECD countries, which were combined by using 
Boolean operators such as “AND” and “OR”. 
Additional articles were identified by hand searching the reference lists of all relevant texts. All citations were 
imported into Refworks bibliographical manager. 
2.3. Data Extraction and Analysis 
BS, EO and IT screened the titles and abstracts of all the citations to identify potentially eligible articles using a 
priori inclusion and exclusion criteria. The three authors independently screened and critically appraised the 
full-text reports of all potentially eligible studies using a piloted eligibility checklist. Data were then extracted 
from all eligible studies using a piloted data extraction form adapted from the Cochrane Collaboration guidelines 
[10]. Disagreements were discussed and resolved through consensus. A narrative synthesis of data was carried 
out as a meta-analysis was not appropriate due to the heterogeneity of the included studies.  
2.4. Quality Assessment/Risk of Bias 
BS and EO independently assessed the quality of the included studies using the Effective Public Health Practice 
Project (EPHPP) Quality Assessment Tool for Quantitative Studies [11]. The tool assesses studies against selec-
tion bias, study design, confounders, blinding, data collection methods, attrition, intervention integrity and data 
analyses, which it provides “strong”, “moderate” or “weak” quality rating. Potential important confounding 
variables such as patients’ age, sex, race/ethnicity and case mix that were identified in other HIV intervention 
studies were also evaluated [12] [13]. Uncertainties in quality assessment were resolved through arbitration with 
another reviewer (IT).  
3. Results 
3.1. Search Results 
2,327 citations from electronic searches and 65 additional reports from manual search of the reference lists of 
relevant reports were identified. After removing duplicates and irrelevant reports, nine studies with 27,015 par-
ticipants were included in the review. The majority of the excluded reports were review articles or studies that 
focused on care settings rather than healthcare professionals. Figure 1 shows the PRISMA flow diagram. 
3.2. Characteristics of Included Studies 
The characteristics and findings of the nine included studies are summarized in Table 1. All nine studies were 
non-randomized studies: two were retrospective cohort studies [14] [15], four were prospective cohort studies 
[16]-[19] and three were cross-sectional studies [20]-[22]. 
All but one of the included studies were carried out in the USA. The non-USA study was conducted in Swit-
zerland. Eight studies were conducted in outpatient settings [14]-[18] [20]-[22] and one study was carried out in 
an inpatient hospital setting [19]. Two of the studies in the USA were conducted in a treatment network in New 
York [14] and California [15], three were conducted with patients within existing research studies across the 48 
contiguous states [16] [19] [21], two were done in federally funded HIV clinics across the USA [18]-[22] and 
one was done using public and medical records of women receiving government medical care benefits in New 
York [20]. The Swiss study was conducted in a teaching outpatient clinic and general practices in urban Zurich 
[17]. 
There was considerable variation across the studies in terms of definition and training of the different HIV 
care providers such as infectious disease (ID), HIV experts, HIV specialists, and generalist; and the comparisons  
B. Sokhom et al. 
 
 164 
 
Figure 1. Study selection flow diagram.                                                                 
 
between these different providers. 
3.3. Quality Assessment 
Five studies were considered to have “strong” overall quality rating [14]-[18], while three studies were rated 
“moderate” [19] [20] [22] and one study was rated “weak” [21] (Table 2). 
All of the included studies controlled for at least four of the six important confounding variables: age, sex, 
race/ethnicity, HIV risk, insurance status and case mix (Table 3). 
3.4. Reported Outcomes 
Twenty-five different outcomes were reported across the nine studies (Table 4).  
3.4.1. Viral Load 
Five studies [14] [15] [17] [18] [22] measured viral load; of which, three studies show significant differences in 
viral loads depending on the care provided by different healthcare personnel. 
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Table 1. Summary of included studies’ characteristics and findings.                                                                                       
Author/ 
Publication  
year 
Country Study Design 
Study  
population/ 
setting 
Intervention Outcomes Notes 
Chu  
2010  
(14) 
New York, 
USA 
Retrospective 
cohort study. 
Data  
collected  
for years 
2005-2008 
Non-pregnant HIV 
positive adults 18+ 
years on cART in 
community-based 
primary care 
network (CB)  
(n = 178) vs. a 
large tertiary care 
center and  
teaching hospital 
(HB) (n = 237) 
CB: 
non-HIV-expert 
PCP in  
collaboration  
with accredited  
HIV specialists  
(all general  
internal/family 
medicine-trained) 
vs. HB: ID-trained 
clinicians 
 CB HB Fewer patients  
initiating cART  
than needed for  
statistical  
significance.  
Data were  
adjusted for  
patients’  
characteristics. 
VL adj OR 1.22, 95% CI 0.41 to 3.63. 
CD4 count adj OR 0.76, 95% CI 0.47 to 1.21 
Gardner  
2002 (21) USA 
Cross-section
al analysis. 
Data  
collected  
for years 
1998-1999 
HIV-infected 
women  
(n = 273) 
HIV-specialist  
care vs. 
non-HIV-specialist 
care. 
 HIV-specialist Non-HIV-specialist Self-reported  
use of ART.  
Analysis  
for use of  
ART was adjusted 
for significant  
predictors that  
led women to use 
HIV-specialist  
care. Provider  
type based on  
self-report by  
patients. Data on  
types of ART use  
were adjusted for 
patients’  
characteristics.  
All other data,  
no adjustment  
was stated. 
ART use 
 -CD4 cell count < 200 (P = 0.6) 
 -CD4 cell count 200 - 500 (P ≤ 0.001) 
 -CD4 cell count > 500 (P = 0.45) 
 -All CD4 cell count groups (P < 0.001) 
PJP  -CD4 cell count < 100/mm3 (P = 0.19) 
Horberg  
2012 (15) 
California, 
USA 
Retrospective 
cohort  
analysis.  
Data  
collected  
for years 
1996-2006 
HIV-infected 
patients  
initiating  
a new cART 
regimen  
(n = 7.071)  
or initiating a 
second or later 
cART  
(n = 3730)  
in an  
integrated  
healthcare  
system 
Non-ID/non-HIV-
expert PCP vs.  
non-ID but 
HIV-expert  
PCP vs. ID  
specialists vs. 
HIV-trained  
NP/PA 
 
Non-ID/ 
non-HIV 
expert 
Non-ID, 
HIV 
expert 
ID  
specialist 
NP/ 
PA 
All data were  
adjusted for  
clustering effect  
and patients’  
characteristics.  
Clinicians with  
more HIV  
caseload  
(adj P = 0.03)  
and experience  
(adj P = 0.003)  
was significant  
in VL success  
after 12 months  
of cART  
initiation  
among  
ART-naïve  
patients but not 
ART-experienced 
patients  
(caseload: adj  
P = 0.96;  
experience: adj  
P = 0.98). 
VL 
Undetectable at 12 months in: 
 -ART-naïve patients (adj P = 0.36) 
 -ART-experienced patients (adj P = 0.80) 
ART  
adherence 
 -ART-naïve patients (adj P = 0.97) 
 -ART-experienced patients (adj P = 0.66) 
Landon  
2003 (16) USA 
Prospective 
cohort study. 
Data  
collected  
for years 
1998-1999 
Non-institutionaliz
ed HIV  
patients  
participating  
in a research study  
(n = 1820). 
ID-trained  
physicians vs.  
GM HIV-expert 
physicians vs.  
GM  
non-HIV-expert 
physicians 
 ID physician GM HIV-expert 
GM 
non-H
IV 
expert 
All data were  
adjusted for  
patients’  
characteristics. 
Appropriate 
cART  
therapy  
at 12 & 18 
months  
after first 
protease 
inhibitor 
approval 
 -GM (HIV-expert and non-HIV-expert) vs. 
ID physicians: adj OR 0.69, 95% CI 0.52 to 
0.95 
 -non-HIV-expert GM vs. ID physicians: adj  
OR 0.32, 95% CI 0.17 to 0.61 
 -HIV-expert GM vs. ID physicians: adj OR 
0.80, 95% CI 0.59 to 1.10. 
 -Low-volume physicians vs. high-volume 
physicians OR 0.26, 95% CI 0.14 to 0.48 
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Landon  
2005  
(18) 
USA 
Prospective 
cohort  
study. Data 
collected for 
years  
2000-2005 
HIV patients age 
18+ in federally 
funded HIV clinics 
(community health 
centers,  
community-based 
organisations, 
health  
departments, 
hospital outpatient 
clinics, university 
medical centers)  
(n = 5247). 
ID physicians  
vs. (HIV-expert) 
GM physicians vs. 
(non-HIV-expert) 
GM physicians 
 
ID  
physician HIV-expert Non-HIV-expert After  controlling for 
specialty training, 
caseload and 
knowledge, 
non-HIV-expert 
GM’s overall  
quality of care is 
lower than ID 
physicians and 
HIV-expert  
GM (adj  
P = 0.02).  
Caseload  
differences not  
statistically  
significant. All 
data were adjusted 
for patients’  
characteristics. 
cART therapy 
ID physicians and  
HIV-expert GM vs. non-HIV-expert  
GM, 80% vs. 73% (P < 0.001) 
VL control 
ID physicians (41%) vs.  
HIV-expert GM (39%) vs.  
non-HIV-expert GM (31%) (P = 0.01) 
Flu  
vaccination rate 
ID physicians (54%) vs.  
HIV-expert GM (49%) vs.  
non-HIV-expert GM (41%) (P < 0.01) 
PJP, PPD, 
HCV, Pap 
smear 
No statistical significant difference 
Outpatient visit 
ID physicians (66%) vs. HIV-expert  
generalists (69%) vs. non-HIV-expert  
generalists (57%) (P < 0.01) 
Page  
2003  
(17) 
Zurich,  
Switzerland 
Prospective 
cohort study. 
Data  
collected for 
years  
1999-2001 
HIV patients on 
ART receiving 
care in an urban 
area in general 
practices vs. a 
specialized  
university o 
utpatient clinic  
(n = 106) 
GP vs. ID  
specialists vs. 
shared care  
between GP  
and ID  
specialists. 
 GP ID 
Shared  
care Significance 
*= Data measured 
at baseline only. 
No adjustment  
was made because 
patients in all 
healthcare  
provider groups 
had similar  
baseline  
characteristics. 
Median CD4 
count 
459  
cells/µl 
(range:  
120 - 
1442) 
449 
cells/µl  
(79 - 
891) 
303.5  
cells/µl  
(104 - 
751) 
No 
% of patients 
with VL < 400 
copies/ml 
72.1% 74.2% 87.5% No 
Mean quality of 
life of all 
participants 
129.5 ± 22.5 baseline,  
131.6 ± 25.6 at study end No 
Mean patient 
satisfaction* 
Patients with GP and shared 
care are more satisfied than 
those with ID specialists 
P < 0.05 
ART use No statistical significant difference 
Patient’s  
evaluation of 
providers 
GP received statistically significantly higher 
mean scores for many dimensions of care (such 
as competence, information, communication, 
time and trust) than ID specialists. 
Mean rate of 
ART  
adherence 
No statistical significant difference 
Schneider 
2008  
(19) 
USA 
Prospective 
cohort study. 
Data collected 
for years 
2001-2003 
HIV patients 
admitted to a 
general  
medicine, 
non-critical  
care inpatient 
services in  
six institutions  
(n = 1207). 
Hospitalists  
(spend at least  
25% of time  
in GM services) vs. 
non-hospitalists 
(spend less than 
25% of time  
in GM services). 
 Hospitalist Non-hospitalist 
Readmission  
rates, emergency 
department visits 
and health status 
were self-reported. 
No clear  
descriptions of 
hospitalists and 
non-hospitalists 
besides the amount 
of time they spend 
in GM inpatient 
care. All data were 
adjusted for  
patients’  
characteristics, 
physicians’  
experience, care 
sites and time  
of hospital  
admission. 
In-hospital 
mortality rate adj P = 0.38 
6-month  
mortality rate adj P = 0.57 
30-day  
readmission 
rate 
adj P = 0.99 
30-day  
emergency 
department  
visit rate 
adj P = 0.70 
30-day  
reported  
health 
adj P = 0.97 
Overall  
patient  
satisfaction 
adj P = 0.98 
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Length of 
hospital stay adj P = 0.13 
 
Total  
hospital costs adj P = 0.4 
Inpatient  
medical  
doctor  
coordination 
with PCP 
adj P = 0.87 
Pain  
controlled 
during  
hospitalization 
adj P = 0.55 
Patient  
understanding 
of reasons for 
hospitalization 
adj P = 0.20 
PJP  
vaccination 
during  
hospitalization 
adj P = 0.99 
Turner  
2001  
(20) 
New York, 
USA 
Cross-sectional 
analysis. Data 
collected for 
years 1996-1998 
HIV women 
receiving federal 
medical care 
benefits  
(n = 595). 
HIV-focused care 
(providers paid at 
enhanced rates to 
deliver 
HIV-related  
services or in an 
HIV-related  
specialty) vs. 
non-HIV-focused 
care 
 HIV-focused Non-HIV-focused 
Participants  
excluded due to 
small sample size: 
Asian Americans, 
American Indians 
and those who  
lack data on  
racial/ethnic  
group or maternal 
country of birth. 
All data were 
adjusted for  
clustering effect, 
patients’ and  
care sites’  
characteristics. 
ART use 
-Compared to patients with 0 visit to  
HIV-focused care, patients with 1 - 2  
HIV-focused visits were statistically  
significant (adj P = 0.02) in receiving  
more acceptable ART combination and not 
significant (adj P = 0.61) in receiving cART. 
-Patients without clinical AIDS benefit from a 
greater visit to HIV-focused care in being 
prescribed cART compared to those with  
AIDS (adj P = 0.02) 
-Among women without AIDS, greater visits  
to HIV-focused care were more likely to be 
prescribed cART (adj OR 1.62, 95% CI 1.10  
to 2.40) than those without HIV-focused care 
Wilson  
2005  
(22) 
USA 
Cross-sectional 
analysis. Data 
collected for 
years 1999-2001 
Persons with  
HIV or  
AIDS in  
federally  
funded HIV  
care sites in  
30 states  
(n = 6551). 
ID-trained  
physicians vs. 
HIV-expert GM 
vs. 
non-HIV-expert 
GM vs. 
HIV-trained 
NP/PA 
 ID  physician 
HIV-ex
pert 
GM 
Non-HI
V-exper
t GM 
NP/PA 
All data  
were adjusted for 
clustering effect, 
study sites, time of 
intervention and 
patients’  
characteristics. 
cART use, viral 
load control, 
influenza 
vaccine use, 
and outpatient 
visit rates 
NP/PA performed better than non-HIV-expert 
GM (P < 0.05), but similar to ID-trained 
physicians and HIV-expert GM: 
-HIV-trained NP/PA outperformed 
non-HIV-expert GM in virological success  
(adj P = 0.012) but not ID physicians (adj  
P = 0.31) and HIV-expert GM (adj P = 0.86) 
-No difference in cART use between ID 
physician (adj P = 0.29) and HIV-expert  
GM (adj P = 0.58) compared to NP/PA.  
Low cART use in non-HIV-expert GM (adj  
P = 0.041) compared to NP/PA 
-NP/PA had higher rate of influenza  
vaccination than non-HIV-expert GM (adj  
P = 0.02) 
-Compared to NP/PA, no difference in  
outpatient visits in ID physicians (adj  
P = 0.125) and HIV-expert GM (adj P = 0.59) 
compared to NP/PA but low outpatient  
visits in non-HIV-expert GM (adj P < 0.001) 
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PJP  
prophylaxis  
and HCV 
testing 
NP/PA vs. GM physicians no  
statistical significant difference 
 
PPD testing 
Compared to NP/PA (rate = 0.63), ID  
physicians (rate = 0.53; adj P = 0.007), 
HIV-expert GM (rate = 0.47; adj P < 0.001) 
and non-HIV-expert GM  
(rate = 0.49; adj P = 0.007) 
Pap smear 
testing 
Compared to NP/PA (rate = 0.71), ID  
physicians (rate = 0.56; adj P = 0.001), 
HIV-expert GM (rate = 0.62; adj P = 0.025) 
and non-HIV-expert GM  
(rate = 0.52; adj P = 0.004) 
Notes: Adj = Adjustment or adjusted. ART=Antiretroviral therapy. cART = Combination antiretroviral therapy. CI = Confidence interval. GM = General medi-
cine. GP = General practitioners. HCV = Hepatitis C virus. HIV = Human immunodeficiency virus. ID = Infectious disease. NP = Nurse practitioners. OR = 
Odds ratio. P = P-value. PA = Physician assistants. PCP = Primary care providers. PJP = Pneumocystis jiroveci pneumonia. PPD = Purified protein derivatives. 
USA = United States of America. VL = Viral load. In all included studies, the level of statistical significance was set at 5%, with a p-value of ≤0.05 indicating a 
statistically significant result. 
 
Table 2. Summary of the quality assessment of the included studies*.                                                                                       
Study 
Minimizing 
selection  
bias1 
Study  
design1 
Control of 
confounders1 Blinding
1 
Data  
collection 
methods1 
Attrition1 Overall  rating2 
Chu 2010 (14) Moderate Moderate Strong Moderate Strong Strong Strong 
Gardner 2002 (21) Strong Weak Strong Moderate Weak NA Weak 
Horberg 2012 (15) Strong Moderate Strong Moderate Strong NA Strong 
Landon 2003 (16) Moderate Moderate Strong Moderate Strong Strong Strong 
Landon 2005 (18) Moderate Moderate Strong Moderate Strong Strong Strong 
Page 2003 (17) Moderate Moderate Strong Moderate Strong Strong Strong 
Schneider 2008 (19) Moderate Moderate Strong Moderate Strong Weak Moderate 
Turner 2001 (20) Moderate Weak Strong Moderate Strong Strong Moderate 
Wilson 2005 (22) Moderate Weak Strong Strong Strong NA Moderate 
Notes: *Quality of the study was assessed using the effective public health practice project quality assessment tool for quantitative studies (11). NA = Not ap-
plicable. 1Overall rating: “Strong” = no weak rating, “Moderate” = 1 weak rating and “Weak” = ≥2 weak ratings on the different components of EPHPP Tool. 
2Parameters assessed: minimization of selection bias: strong, the participants were likely; moderate, somewhat likely; weak, not likely, to represent the target 
population. Study design: strong, randomization occurred, e.g. RCTs; moderate, study described as case control, before and after, etc.; weak, study design not 
specified. Confounders: strong, controlled for all relevant confounders; moderate, controlled for some confounders; weak, control for confounders not specified. 
Blinding: strong, the researchers do not know participants’ intervention group and the participants do not know the research question; moderate, the researchers 
do not know participants’ intervention status or the participants do not know the research question or blinding is not stated in the article; weak, the researchers 
know participants’ intervention group and the participants know the research hypothesis. Data collection method: strong, valid and reliable data collection tools; 
moderate, tools valid but not reliable; weak, validity and reliability not described. Withdrawals and dropouts (attrition): strong, reported withdrawals and drop-
outs (80% - 100% of participants completed the study); moderate, reported withdrawals and dropouts (60% of participants completed the study); weak, with-
drawal and dropout rates not specified. 
 
Table 3. Summary of potential confounders controlled for in the included studies.                                            
Study 
Potential confounders controlled for in the study 
Age Sex Race/ethnicity HIV risk Insurance status Case mix 
Chu 2010 (14) Yes Yes Yes Yes Yes Yes 
Gardner 2002 (21) Yes NA No Yes Yes Yes 
Horberg 2012 (15) Yes Yes Yes Yes NA Yes 
Landon 2003 (16) Yes Yes Yes Yes Yes Yes 
Landon 2005 (18) Yes Yes No No NA Yes 
Page 2003 (17) NA—same baseline characteristics for patients in different intervention arms 
Schneider 2008 (19) Yes Yes Yes No Yes Yes 
Turner 2001 (20) Yes NA Yes No NA Yes 
Wilson 2005 (22) Yes Yes No Yes NA Yes 
Note: NA = Not applicable. 
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Table 4. Summary of included studies’ outcome measurements.                                                           
Study 
Outcome Measures 
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Chu  
2010 (14) Y Y Y N N N N N N N N N N N N N N N N N N N N N N 
Gardner 
2002 (21) N N Y Y N Y N N N N N N N N N N N N N N N N N N N 
Horberg 
2012 (15) Y N N N N N N N N N N N N N N N N N N N N N N N N 
Landon  
2003 (16) N N N N Y N N N N N N N N N N N N N N N N N N N N 
Landon  
2005 (18) Y N N N Y Y Y Y Y Y N N N N N N N N N N N N N N Y 
Page  
2003 (17) Y Y N N Y N N N N N N N N N N N N N N N N N N N N 
Schneider 
2008 (19) N N N N N Y N N N Y Y Y Y Y Y Y Y Y Y N Y Y N N N 
Turner  
2001 (20) N N Y N N N N N N N N N N N N N N N N N N N N N N 
Wilson  
2005 (22) Y N N N Y Y Y Y Y Y N N N N N N N N N N N N N N Y 
Notes: “Y” = Measurement included in the study. “N” = No measurement. ART = Antiretroviral therapy; cART = Combination antiretroviral therapy; 
ER = Emergency room; HCV = Hepatitis C virus; HIV = Human immunodeficiency virus; OP = Outpatient; PJP = Pneumocystis jiroveci pneumonia; 
PPD = Purified protein derivatives. 
 
In the study by Horberg et al. [15], while there was no statistical difference in virologic success between 
ART-naïve (P = 0.36) and ART-experienced patients (P = 0.80) treated by non-infectious diseases (ID)/non- 
HIV-expert primary care providers (PCP), non-ID/HIV-expert PCP, ID specialists and HIV-trained nurse practi-
tioner (NP) or physician assistant (PA) after 12 months of cART initiation, more ART-naïve patients under cli-
nicians with more HIV caseload (P = 0.03) and HIV experience (P = 0.003) were able to achieve virologic success. 
Landon et al., [18] observed that ID physicians and HIV-expert generalists were better at controlling patients’ 
viral load than non-HIV-expert generalists (P < 0.001). After controlling for providers’ specialty training, HIV 
caseload and knowledge, the study still showed that patients under non-HIV-expert generalists had lower rates 
of virologic success than other clinicians within the study. However, the study found no significant difference in 
the outcome between the different clinicians when looking at HIV caseload alone. 
Additionally, Wilson and colleagues [22] found that HIV-trained NP and PA performed better in viral load 
control than non-HIV-expert generalists, but comparable to ID physicians and HIV-expert generalists. 
3.4.2. CD4 Cell Count 
Two studies [14] [17] measured CD4 cell count. Chu et al., [14] found no significant difference in achieving 
immunologic success among patients cared for by non-HIV-expert PCP in collaboration with HIV specialists 
and ID clinicians with NP or PA (OR = 0.76, 95% CI 0.47 to 1.21). Page et al., [17] also found no statistical 
difference in the median CD4 cell count between patients cared for by general practitioner (GP) actively 
treating HIV patients in their practices, ID specialists and those in shared care (i.e. patients who were seeing 
both specialists and GP at the same time) over a one-year period. 
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3.4.3. Antiretroviral Therapy 
Seven studies [14] [16]-[18] [20]-[22] measured various ART-related outcomes such as selection of cART and 
medical advice for ART. 
Two studies found that patients cared for by clinicians without HIV-related training or experience were less 
likely to be on cART (OR = 0.32, 95% CI 0.17 to 0.61), [16] and less likely to receive cART (P < 0.001), [18] 
when compared to clinicians with HIV-related training and experience and/or clinicians without HIV-related 
training and experience collaborating with those with HIV-related expertise. 
Furthermore, Wilson et al., [22] observed lower cART use among patients under non-HIV-expert generalists 
when compared to those under HIV-trained NP and PA, who had similar rate of cART use as HIV-expert gener-
alists’ and ID physicians’ patients. 
Turner et al., [20] reported that women with HIV-focused care visits, defined as visits to clinicians who were 
paid at a higher rate to provide HIV-related services or those in an HIV-related specialty were more likely to re-
ceive acceptable ART combinations than those not receiving any HIV-focused care (Table 1). However, when 
stratifying patients into those with AIDS and those without, the study authors found that women without AIDS 
benefitted from greater visits to HIV-focused care than those with AIDS (P = 0.02). Nonetheless, among women 
without AIDS, three or more HIV-focused care visits was associated with appropriate cART use compared to 
those without HIV-focused care visit (OR = 1.62, 95% CI 1.10 to 2.40). 
Similarly, Gardner et al., [21] observed that more patients who self-reported to attend HIV-specialist clinics 
received advice to begin ART (P < 0.001) and received appropriate cART and non-cART (monotherapy or 
combination ART without protease inhibitor or non-nucleoside reverse transcriptase inhibitor) (P < 0.001) than 
those attending non-HIV-specialist clinics. Yet, the level of significance was only observed in patients with CD4 
cell count between 200 and 500 cells/mm3 (P < 0.001 and P = 0.009, respectively). In this study, attending HIV 
specialist clinics did not necessarily mean that patients received care from HIV specialists. 
3.4.4. Opportunistic Infection Prophylaxis 
Four studies, [18] [19] [21] [22] had outcome measurements associated with opportunistic infection prophylaxis. 
All four studies measured the use of Pneumocystis jiroveci pneumonia (PJP) prophylaxis and found no dif-
ferences in its use between ID physicians, HIV-expert generalists and non-HIV-expert generalists [18]; hospital-
ists and non-hospitalists (P = 0.99) [19]; HIV-specialist and non-HIV-specialist clinics for women who had CD4 
cell counts less than 100 cells/mm3 (P = 0.19) [21]; and ID physicians, HIV-expert generalists, non-HIV-expert 
generalists and HIV-trained NP or PA [22]. 
Two studies measured hepatitis C screening but did not find any difference between ID physicians, HIV-ex- 
pert generalists and non-HIV-expert generalists [18], and ID physicians, HIV-expert generalists, non-HIV-ex- 
pert generalists and HIV-trained NP or PA [22]. 
Additionally, Landon et al., [18] did not find any difference in the use of purified protein derivatives (PPD) 
testing for tuberculosis, hepatitis C screening and Pap smear among different clinicians. However, the study au-
thors found that ID physicians and HIV-expert generalists significantly provided more influenza vaccination to 
their patients than non-HIV-expert generalists (P < 0.01). 
Wilson et al., [22] however found that HIV-trained NP or PA outperformed ID physicians, HIV-expert gener-
alists and non-HIV-expert generalists in PPD testing of their patients and providing Pap smear. The same study 
found that patients cared for by HIV-trained NP or PA had significantly higher rate of influenza vaccination than 
patients under the care of non-HIV-expert generalists (P = 0.02). 
3.4.5. Hospital Care and Costs 
Only one study, [19] measured hospital-related care and costs and found no significant differences in all out-
come measurements between HIV patients under the care of hospitalists and non-hospitalists (Table 1), includ-
ing the rate of in-hospital mortality (rate = −1.7%, 95% CI −1.8 to −1.5, P = 0.38) and six-month mortality rate 
−1.6%, 95% CI −1.7 to −1.5, P = 0.57). 
3.4.6. Psychosocial Outcome 
Two studies [17] [19] measured patients’ psychosocial outcomes such as quality of life and patient satisfaction. 
Page et al., [17] did not find any difference in patients’ mean quality of life between patients who were cared 
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for by GP actively treating HIV patients, ID specialists and shared care after 12 months of care. Yet, compared 
to patients cared for by ID specialists, patients with GP (P < 0.05) and shared care (P < 0.05) had significantly 
higher patient satisfaction. 
Schneider et al., [19] observed no significant difference in 30-day self-reported health status (rate = −0.2%, 
95% CI −0.2 to −0.2, P = 0.97) and overall patients’ self-rated satisfaction (−0.1%, 95% CI −0.1 to −0.7, P = 
0.98) between patients under the care of hospitalists and non-hospitalists. 
3.4.7. Behavioural Outcome 
Four studies [15] [17] [18] [22] assessed patients’ ART adherence or outpatient visits. 
3.5. ART Adherence 
Horberg et al., [15] found no significant difference in ART adherence in ART-naïve patients (P = 0.97) and 
ART-experienced patients (P = 0.66) under the care of non-ID/non-HIV-expert PCP, non-ID/HIV-expert PCP, 
ID specialists and HIV-trained NP or PA. In addition, Page et al., [17] observed no significant difference in 
ART adherence between patients who received care from GP actively treating HIV patients, ID specialists or 
shared care. 
3.6. Outpatient Visit 
Landon et al., [18] found that patients receiving care from ID physicians or HIV-expert generalists had signifi-
cantly greater outpatient visits than patients under the care of non-HIV-expert generalists (P < 0.01). Addition-
ally, Wilson et al., [22] observed that outpatient visit rates among ID physicians, HIV-expert generalists and 
HIV-trained NP or PA were comparable. However, patients under HIV-trained NP or PA had significantly 
higher rate of outpatient visits than those under non-HIV-expert generalists (P < 0.001). 
Non-HIV Related Outcomes and cART Interactions 
None of the included studies reported any outcome related to medication errors, adverse drugs reactions and 
chronic diseases associated with long-term HIV care. 
4. Discussion 
While some studies included in this review have shown small differences in some outcomes, no conclusive evi-
dence was identified about relative benefits and risks’ regarding which specific type of healthcare provider was 
better at providing medical care to PLWHA. Yet, HIV patients who were cared for by HIV-expert healthcare 
providers (through accredited training or self-identification) and those who have HIV-related specialty (e.g. in-
fectious disease) tend to achieve better virologic, immunologic and ART-related outcomes. When HIV patients 
were cared for by non-HIV-expert healthcare providers, the key to achieving successful outcomes was collabo-
ration with HIV-expert clinicians or ID specialists. None of the included studies observed that healthcare pro-
viders with HIV expertise or HIV-related training performed poorer in the measured outcomes than clinicians 
without HIV-related expertise or specialty. 
There is not enough evidence in this review to suggest that HIV care providers with greater caseloads-a proxy 
for experience-have better outcomes and improved patient survival [12]. For instance, Horberg et al., [15] ob-
served that healthcare providers’ HIV experiences only influenced patients’ virologic success in ART-naïve pa-
tients and did not affect ART adherence in both ART-naïve and ART-experienced patients. Additionally, 
Landon et al., [18] found caseload to cause no effect on any of their eight quality-of-care measures. On the other 
hand, after adjusting for clinicians’ training and HIV expertise, Landon et al., [16] observed patients under the 
care of clinicians with lower HIV caseload had lower odds of being on cART 12 months after the approval of 
the first protease inhibitor and no significant effects 18 months after. These mixed results could be attributed to 
the complexities of ART regimen in which healthcare providers with more HIV-related experience were better 
informed than their less experienced colleagues. Yet, some of these findings, as observed in Landon et al., [16] 
indicate that over time generalists are able to develop expertise specifically around ART that is comparable to 
that of specialists. 
Findings from this review were observed to agree with a review by Rackal et al., [13] which examined the ef-
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fects of providers’ training and experience on the quality of HIV care. In their review, they found that patients 
cared for by clinicians with HIV training or expertise had better medical and social outcomes than patients under 
clinicians without any HIV training or expertise. However, the authors were unable to find any association be-
tween the quality of care and providers’ HIV experience. 
Furthermore, evidence from this review shows that quality of care, adherence to treatment, [15] and use of 
cART, [16] [18] were not affected by the caseload or experience of the provider. This is in contrast to the find-
ings by Handford et al., [12] who found that HIV clinicians’ with higher number of patients or greater experi-
ence with HIV patients had higher use of cART and decreased patients’ mortality. This contrast could be attrib-
uted to different care settings and level of HIV experience considered in the reviews. 
This systematic review has some important limitations. Only two of the included studies were published in the 
preceding five years and HIV care and treatment has evolved rapidly since then. No study reported on non-HIV 
related outcomes and cART interactions with other drugs even though these outcomes present major challenges 
particularly in older PLWHA with co-morbidities. Additionally, due to the small number of studies, their obser-
vational nature and the heterogeneity of the interventions and quality of care outcomes, a meta-analysis could 
not be performed. It is also important to note that in some of these studies, a small number of the outcome 
measurements were self-reported, mainly ART adherence and outpatient visits. In some studies, clinicians’ HIV 
expertise was self-reported and was not confirmed by the study authors [16] [18] [22]. However, in this review 
we explicitly stated which outcomes or clinicians were self-reported. Furthermore, all but one of the included 
studies were conducted in the USA [17]. As HIV specialist training and health systems are different in many 
developed countries, including within the USA itself, evidence observed in this review needs to be interpreted 
with caution especially when applying such findings to other settings with different healthcare systems, training 
and social health coverage. In spite of these limitations, most of the studies had adequate controls for important 
confounding variables associated with patient and provider characteristics and most of the studies were of high 
quality. 
5. Conclusions 
In summary, this review provides some evidence for healthcare providers and policy makers to consider when 
providing medical care to PLWHA. Clinicians without HIV-related expertise or specialty were observed to per-
form poorer in some important dimensions of HIV care such as viral load control and use of cART. 
Therefore, it is pertinent that clinicians who have limited HIV knowledge or expertise of caring for PLWHA 
should seek to gain more HIV knowledge and expertise or work in collaboration with HIV-trained clinicians and 
experts. 
More high quality studies to assess the effectiveness of HIV care and treatment provided by different health-
care providers in developed countries are needed. Such studies should examine not only the virological or im-
munological outcomes of HIV care and treatment, but also other clinical outcomes relating to medication errors, 
knowledge of drug interactions and patient’s quality of life. 
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Abbreviations and Acronyms 
ART = antiretroviral therapy;  
cART = combination antiretroviral treatment;  
CI = confidence interval;  
GP = general practitioner;  
HIV = human immunodeficiency virus;  
ID = infectious disease;  
LMICS = low and middle-income countries;  
NP = nurse practitioner;  
OECD = Organisation for Economic Cooperation and Development;  
PA = physician assistant;  
PCP = primary care provider;  
PJP = Pneumocystic jiroveci pneumonia;  
PLWHA = people living with HIV/AIDS;  
PPD = purified protein derivatives. 
 
 
 
